Healthcare -
Biotechnology - NASDAQ - US
$ 1.5049
13.2 %
$ 106 M
Market Cap
-2.25
P/E
SLS - TOTAL CURRENT ASSETS
Total Current Assets SLS - SELLAS Life Sciences Group, Inc.
3.17 M
LAST VALUE
-62.90%
2 YEAR CAGR
-11.49%
5 YEAR CAGR
-24.61%
10 YEAR CAGR